| Literature DB >> 32278725 |
Vivek N Prachand1, Ross Milner2, Peter Angelos2, Mitchell C Posner2, John J Fung2, Nishant Agrawal2, Valluvan Jeevanandam2, Jeffrey B Matthews2.
Abstract
Hospitals have severely curtailed the performance of nonurgent surgical procedures in anticipation of the need to redeploy healthcare resources to meet the projected massive medical needs of patients with coronavirus disease 2019 (COVID-19). Surgical treatment of non-COVID-19 related disease during this period, however, still remains necessary. The decision to proceed with medically necessary, time-sensitive (MeNTS) procedures in the setting of the COVID-19 pandemic requires incorporation of factors (resource limitations, COVID-19 transmission risk to providers and patients) heretofore not overtly considered by surgeons in the already complicated processes of clinical judgment and shared decision-making. We describe a scoring system that systematically integrates these factors to facilitate decision-making and triage for MeNTS procedures, and appropriately weighs individual patient risks with the ethical necessity of optimizing public health concerns. This approach is applicable across a broad range of hospital settings (academic and community, urban and rural) in the midst of the pandemic and may be able to inform case triage as operating room capacity resumes once the acute phase of the pandemic subsides.Entities:
Mesh:
Year: 2020 PMID: 32278725 PMCID: PMC7195575 DOI: 10.1016/j.jamcollsurg.2020.04.011
Source DB: PubMed Journal: J Am Coll Surg ISSN: 1072-7515 Impact factor: 6.113
Procedure Factors
| Variable | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|
| OR time, min | <30 | 31–60 | 61–120 | 121–180 | ≥181 |
| Estimated LOS | Outpatient | <23 h | 24–48 h | 2–3 d | ≥4 d |
| Postoperative ICU need, % | Very unlikely | <5 | 5–10 | 11–25 | >25 |
| Anticipated blood loss, cc | <100 | 100–250 | 250–500 | 500–750 | ≥751 |
| Surgical team size, n | 1 | 2 | 3 | 4 | >4 |
| Intubation probability, % | ≤1 | 1–5 | 6–10 | 11–25 | >25 |
| Surgical site | None of the following row variables | Abdominopelvic MIS | Abdominopelvic open surgery, infraumbilical | Abdominopelvic open surgery, supraumbilical | OHNS/upper GI/thoracic |
GI, gastrointestinal; LOS, length of stay; MIS, minimally invasive surgery; OHNS, otolaryngology, head & neck surgery; OR, operating room.
Disease Factors
| Factor | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|
| Nonoperative treatment option effectiveness | None available | Available, <40% as effective as surgery | Available, 40% to 60% as effective as surgery | Available, 61% to 95% as effective as surgery | Available, equally effective |
| Nonoperative treatment option resource/exposure risk | Significantly worse/not applicable | Somewhat worse | Equivalent | Somewhat better | Significantly better |
| Impact of 2-wk delay in disease outcome | Significantly worse | Worse | Moderately worse | Slightly worse | No worse |
| Impact of 2-wk delay in surgical difficulty/risk | Significantly worse | Worse | Moderately worse | Slightly worse | No worse |
| Impact of 6-wk delay in disease outcome | Significantly worse | Worse | Moderately worse | Slightly worse | No worse |
| Impact of 6-wk delay in surgical difficulty/risk | Significantly worse | Worse | Moderately worse | Slightly worse | No worse |
Patient Factors
| Factor | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|
| Age, y | <20 | 21–40 | 41–50 | 51–65 | >65 |
| Lung disease (asthma, COPD, CF) | None | – | – | Minimal (rare inhaler) | > Minimal |
| Obstructive sleep apnea | Not present | – | – | Mild/moderate (no CPAP) | On CPAP |
| CV disease (HTN, CHF, CAD) | None | Minimal (no meds) | Mild (1 med) | Moderate (2 meds) | Severe (≥3 meds) |
| Diabetes | None | – | Mild (no meds) | Moderate (PO meds only) | > Moderate (insulin) |
| Immunocompromised | No | Moderate | Severe | ||
| ILI symptoms (fever, cough, sore throat, body aches, diarrhea) | None (Asymptomatic) | – | – | – | Yes |
| Exposure to known COVID–19 positive person in past 14 days | No | Probably not | Possibly | Probably | Yes |
CAD, coronary artery disease; CF, cystic fibrosis; CHF, congestive heart failure; COVID-19, novel coronavirus; CPAP, continuous positive airway pressure; CV, cardiovascular; HTN, hypertension; ILI, influenza-like illness; med, medication; PO, by mouth.
Hematologic malignancy, stem cell transplant, solid organ transplant, active/recent cytotoxic chemotherapy, anti-TNFα or other immunosuppressants, >20 mg prednisone equivalent/day, congenital immunodeficiency, hypogammaglobulinemia on intravenous immunoglobulin, AIDS.
Figure 1Use of the cumulative medically necessary time-sensitive (MeNTS) score. Upper and lower threshold MeNTS scores can be assigned and dynamically adjusted to respond to the immediate and anticipated availability of resources and local conditions while preserving operating room capacity for trauma, emergency, and highly urgent cases.
Figure 2Proof of concept of the medically-necessary time-sensitive (MeNTS) scoring system. Cumulative MeNTS scores of a sample of MeNTS procedures performed after ad hoc case review (n = 35, green bars) and procedures cancelled (n = 6, red bars) between March 20 and March 26, 2020, after initial cessation of all MeNTS procedures on March 16 were calculated. Y-axis represents the number of cases with a specific MeNTS score. MeNTS cases that were performed had generally lower MeNTS scores than those of cancelled procedures, demonstrating concordance with the ad hoc decisions made before creation of the MeNTS scoring system.